Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 5.26%48.88M | 7.34%49.25M | 17.23%196.68M | 13.69%53.02M | 20.07%51.35M | 18.47%46.44M | 17.11%45.88M | 8.07%167.78M | 15.73%46.63M | 7.04%42.77M |
| Cost of revenue | 4.31%14.21M | 12.45%15.19M | 27.10%61M | 18.10%17.53M | 36.18%16.33M | 27.08%13.62M | 29.48%13.51M | 12.06%47.99M | 31.62%14.84M | 4.03%11.99M |
| Gross profit | 5.65%34.67M | 5.20%34.06M | 13.28%135.69M | 11.63%35.49M | 13.78%35.01M | 15.22%32.81M | 12.62%32.37M | 6.56%119.79M | 9.56%31.79M | 8.26%30.77M |
| Operating expense | 31.77%785.01K | 9.71%651.51K | -1.75%2.46M | 4.59%636.87K | 2.12%633.51K | -4.93%595.75K | -8.34%593.82K | -6.12%2.5M | -4.14%608.92K | -5.49%620.35K |
| Depreciation and amortization | 31.77%785.01K | 9.71%651.51K | -1.75%2.46M | 4.59%636.87K | 2.12%633.51K | -4.93%595.75K | -8.34%593.82K | -6.12%2.5M | -4.14%608.92K | -5.49%620.35K |
| -Depreciation | 31.77%785.01K | 9.71%651.51K | -1.75%2.46M | 4.59%636.87K | 2.12%633.51K | -4.93%595.75K | -8.34%593.82K | -6.12%2.5M | -4.14%608.92K | -5.49%620.35K |
| Other operating expenses | ---- | 33.98%13.2M | 66.40%44.5M | 69.61%12.61M | 73.43%11.11M | 87.08%10.94M | 39.50%9.85M | 254.67%26.74M | 4.84%7.43M | 71.76%6.41M |
| Operating profit | 5.17%33.88M | 5.12%33.41M | 13.60%133.23M | 11.77%34.85M | 14.02%34.38M | 15.68%32.22M | 13.11%31.78M | 6.86%117.28M | 9.87%31.18M | 8.59%30.15M |
| Net non-operating interest income (expenses) | 0 | 0 | ||||||||
| Net investment income | ||||||||||
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 0 | 0 | 453.98%28.92K | -47.84%2.72K | 15.72K | 12.11K | -1.64K | 5.22K | 5.22K | 0 |
| Special income (charges) | 0.79%-10.85M | -33.98%-13.2M | -66.40%-44.5M | -69.61%-12.61M | -73.43%-11.11M | -87.08%-10.94M | -39.50%-9.85M | -254.67%-26.74M | -4.84%-7.43M | -71.76%-6.41M |
| Less:Write off | -0.79%10.85M | 33.98%13.2M | 66.40%44.5M | 69.61%12.61M | 73.43%11.11M | 87.08%10.94M | 39.50%9.85M | 254.67%26.74M | 4.84%7.43M | 71.76%6.41M |
| Other non-operating income (expenses) | -15.99%-11.85M | -6.30%-11.63M | -8.51%-45.04M | -16.89%-12.45M | -6.40%-11.43M | -0.33%-10.21M | -10.19%-10.94M | -6.69%-41.5M | 6.04%-10.65M | -15.70%-10.74M |
| Income before tax | 0.95%11.19M | -21.90%8.58M | -10.85%43.72M | -25.23%9.8M | -8.83%11.85M | -6.31%11.08M | -1.08%10.99M | -22.54%49.04M | 31.61%13.1M | -11.87%13M |
| Income tax | -7.89%2.6M | -24.46%2.15M | -10.56%11.07M | -29.54%2.39M | -11.29%3.01M | -5.53%2.82M | 9.30%2.85M | -20.49%12.38M | 37.76%3.39M | -6.49%3.39M |
| Net income | 3.97%8.59M | -21.00%6.43M | -10.94%32.65M | -23.72%7.41M | -7.96%8.84M | -6.57%8.26M | -4.26%8.14M | -23.21%36.66M | 29.59%9.71M | -13.62%9.61M |
| Net income continuous operations | 3.97%8.59M | -21.00%6.43M | -10.94%32.65M | -23.72%7.41M | -7.96%8.84M | -6.57%8.26M | -4.26%8.14M | -23.21%36.66M | 29.59%9.71M | -13.62%9.61M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 3.97%8.59M | -21.00%6.43M | -10.94%32.65M | -23.72%7.41M | -7.96%8.84M | -6.57%8.26M | -4.26%8.14M | -23.21%36.66M | 29.59%9.71M | -13.62%9.61M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 3.97%8.59M | -21.00%6.43M | -10.94%32.65M | -23.72%7.41M | -7.96%8.84M | -6.57%8.26M | -4.26%8.14M | -23.21%36.66M | 29.59%9.71M | -13.62%9.61M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 4.95%0.0191 | -20.67%0.0142 | -10.92%0.0718 | -23.47%0.0163 | -8.06%0.0194 | -6.19%0.0182 | -4.28%0.0179 | -23.24%0.0806 | 29.88%0.0213 | -13.88%0.0211 |
| Diluted earnings per share | 4.95%0.0191 | -20.67%0.0142 | -10.92%0.0718 | -23.47%0.0163 | -8.06%0.0194 | -6.19%0.0182 | -4.28%0.0179 | -23.24%0.0806 | 29.88%0.0213 | -13.88%0.0211 |
| Dividend per share | 0 | -16.67%0.025 | -9.09%0.05 | 0 | 0.00%0.02 | 0 | -14.29%0.03 | 6.45%0.055 | 0 | -33.33%0.02 |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.